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BACKGROUND: High-resolution melting is an emerging
technique for detection of nucleic acid sequence
variations. Developments in instrumentation and
saturating intercalating dyes have made accurate
high-resolution melting analysis possible and created
opportunities to use this technology in diagnostic set-
tings. We evaluated 2 high-resolution melting instru-
ments for screening BRCA1 and BRCA2mutations.
METHODS: To cover the complete coding region and
splice sites, we designed 112 PCR amplicons (136–435
bp), amplifiable with a single PCR program. LCGreen®
Plus was used as the intercalating dye. High-resolution
melting analysis was performed on the 96-well Light-
scanner™ (Idaho Technology Inc.) and the 96-well
LightCycler® 480 (Roche) instruments. We evaluated
sensitivity by analyzing 212 positive controls scattered
over almost all amplicons and specificity by blind
screening of 22 patients for BRCA1 and BRCA2. In to-
tal, we scanned 3521 fragments.
RESULTS: All 212 known heterozygous sequence vari-
ants were detected on the Lightscanner by analysis
on normal sensitivity setting. On the LightCycler
480, the standard instrument sensitivity setting of 0.3
had to be increased to 0.7 to detect all variants, de-
creasing the specificity to 95.9% (vs 98.7% for the
Lightscanner).
CONCLUSIONS: Previously, we screened BRCA1/2 by di-
rect sequencing of the large exon 11 and denaturing gel
gradient electrophoresis (DGGE) for all other coding
exons. Since the introduction of high-resolution
melting, our turnaround time has been one third of
that with direct sequencing and DGGE, as post-PCR
handling is no longer required and the software allows
fast analyses. High-resolution melting is a rapid, cost-
efficient, sensitive method simple enough to be readily
implemented in a diagnostic laboratory.
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Different approaches are used to screen the complete
coding region of large genes such as BRCA12 (MIM
113705) andBRCA2 (MIM600185), the 2major breast
cancer susceptibility genes. Most commonly, a pre-
screening method such as denaturing high-perfor-
mance liquid chromatography (dHPLC)3 or denatur-
ing gradient gel electrophoresis (DGGE) is used,
followed by sequencing of aberrant fragments. Screen-
ing of BRCA1 and BRCA2 is arduous because of the
complex mutational spectrum and the large size of the
genes for which the complete coding sequence needs to
be analyzed for an increasing number of patients. Both
genes lack mutation hot-spot regions, and different
types of mutations, including frameshift, missense,
nonsense, and splice site, are found. BRCA1 comprises
22 coding exons; the 7.8-kb mRNA transcript is trans-
lated into a protein of 1863 amino acids (1 ). BRCA2
comprises 26 coding exons; the 10-kb mRNA tran-
script is translated into a protein of 3418 amino acids
(2 ).
Until recently, our mutation detection strategy
consisted of direct sequencing of the large exon 11 of
both BRCA1 and BRCA2 and DGGE for all other cod-
ing exons (3, 4). Because we were witnessing an in-
creasing number of patients and aiming at a reduction
of costs and workload, we evaluated 2 high-resolution
melting instruments for mutation screening of both
BRCA1 and BRCA2.
High-resolution melting analysis of nucleic acids
depends on the ability to record and evaluate fluores-
cence intensities as a function of the melting tempera-
1 Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
* Address correspondence to this author at: Center for Medical Genetics, Ghent
University Hospital, De Pintelaan 185, B-9000 Gent, Belgium. Fax 32-
92406549; e-mail Kathleen.Claes@UGent.be.
Received October 14, 2007; accepted February 21, 2008.
Previously published online at DOI: 10.1373/clinchem.2007.098764
2 Human genes: BRCA1, breast cancer 1, early onset; BRCA2, breast cancer 2,
early onset.
3 Nonstandard abbreviations: dHPLC, denaturing high-performance liquid chro-
matography; DGGE, denaturing gradient gel electrophoresis; dsDNA, double-
strand DNA; Tm, melting temperature; SNP, single nucleotide polymorphism.
Clinical Chemistry 54:6
982–989 (2008)
Molecular Diagnostics and Genetics
982
ture of PCRproducts. Themelting behavior of the PCR
products is monitored by plotting the changes in fluo-
rescence that occur by denaturing double-strand DNA
(dsDNA) upon heating. Heterozygous DNA samples
form heteroduplexes, resulting in a different shape of
themelt curve compared with a homozygous reference
sample. The altered melting curve shape is a result of
the presence of both heteroduplex and homoduplex
amplicons in the PCR product, vs only homoduplexes
from normal samples. Mutant homozygous samples,
in contrast, are detected by a melting temperature
(Tm) shift rather than an altered curve shape.
Since the introduction of saturating dsDNA bind-
ing dyes like LCGreen® Plus, the sensitivity and speci-
ficity of DNA melting analysis has increased substan-
tially. Nonsaturating dyes like SYBR Green possibly
allow redistribution of dye molecules from melted re-
gions back into the dsDNA amplicon, resulting in no
change in fluorescent signal even in the presence of a
heteroduplex (5, 6).When a saturating fluorescent dye
is intercalated in dsDNA, dye jumping during ampli-
con melting is prevented, allowing theoretical detec-
tion of all sequence changes.
In the present study, we evaluated high-resolution
melting analysis for BRCA1 and BRCA2 and compared
the LightscannerTM (Idaho Technology Inc.) and the
LightCycler® 480 (Roche) instruments. To determine
sensitivity, we used 212 positive controls scattered over
100 different amplicons. In addition, we performed a
blind screening of 22 patients (i.e., 2464PCR reactions)
to determine the specificity of high-resolution melting
analysis on the 2 instruments.
Materials andMethods
DNA SAMPLES AND STUDY DESIGN
DNA samples from patients with previously character-
ized genetic variants were used as positive controls to
determine the sensitivity of high-resolution melting.
These variants were previously detected with amixture
of other techniques such as DGGE, dHPLC, protein
truncation test (PTT), and sequencing. For BRCA1, 97
positive control samples were available, scattered over
42 of 45 amplicons designed to cover the complete cod-
ing sequence ofBRCA1. For amplicons 11.1, 11.17, and
15.2, we had no positive controls available. We ana-
lyzed 36 deletions (15 of 1 bp, 7 of 2 bp, 2 of 3 bp, 6 of
4 bp, 3 of 5 bp, 2 of 11 bp, and 1 of 62 bp), 12 1-bp
insertions (of which 10were duplications), a combined
delTTinsG mutation and delAGinsT mutation, and an
insertion of an Alu element. Furthermore, we analyzed
29 transitions (15 T/C and 14 A/G) and 17 transver-
sions (3 A/C, 9 G/T, 3 C/G, and 2 T/A).
ForBRCA2, we tested 115 positive control samples
scattered over 58 of 67 amplicons, designed to cover the
complete coding sequence of BRCA2.No positive con-
trols were available for fragments 4, 11.10, 11.13, 12,
21, 26, 27.1, 27.2, or 27.3. For BRCA2, we analyzed 38
deletions (13 of 1 bp, 15 of 2 bp, 9 of 4 bp, and 2 of
7 bp), 7 1-bp insertions (of which 5 were duplications),
46 transitions (19 T/C and 27 A/G), and 24 transver-
sions (8 A/C, 6 G/T, 6 G/C, and 4 A/T). An overview of
all positive controls is given in Supplementary Table 1
in the Data Supplement that accompanies the online
version of this article at http://www.clinchem.org/
content/vol54/issue6. As negative controls, we used
DNA samples from several healthy individuals.
Also, we blindly screened 22 patients for BRCA1
and BRCA2 to determine the specificity of the high-
resolution melting technique. We had previously ana-
lyzed 11 of the patient samples with direct sequencing
of exon 11 of BRCA1/2 and DGGE for all other exons.
We performed a second blind screening of 11 patients
in parallel with direct sequencing of all amplicons.
PRIMERS AND PCR OPTIMIZATION
We designed primers for BRCA1 and BRCA2 to cover
the complete coding region and splice sites encompass-
ing exons 2–24 of BRCA1 (45 amplicons, 21 of which
encompass exon 11) and exons 2–27 of BRCA2 (67
amplicons, 27 of which encompass exon 11). Primer
sequences are available in Supplementary Table 2 in the
online Data Supplement. The absence of SNPs in the
primers was verified with the help of the Ensembl
genomic sequence database. We chose annealing tem-
peratures all around 50 °C and evaluated the specificity
of the primers using the University of California Santa
Cruz in silico PCR program. The amplicon length
ranged between 136 and 435 bp, median 238 bp. To
simplify the sequencing process afterwards, all primers
were fused with universal M13-tails (forward CAC
GACGTTGTAAAACGAC and reverse CAGGAAA
CAGCTATGACC). The dye-stained DNA template
had no interference with the sequencing reactions.
PCRwas performed in 25L volumes. The ampli-
fication mixture included 1.5 mmol/L MgCl2 (Invitro-
gen), 1 PCR buffer (Invitrogen), 3% DMSO (VWR
International), 0.2mol/L of both forward and reverse
primer, 200 mol/L of each dNTP, 0.5 U/L Plati-
num® Taq DNA polymerase (Invitrogen), 0.5
LCGreen Plus, and approximately 100 ng DNA. By
adding 3% DMSO, we could use the same master mix
for almost all fragments. For 3 amplicons (BRCA1
11.14 and BRCA2 11.5 and 11.6), we increased DMSO
concentrations (to 10%, 5%, and 7%, respectively) to
obtain specific PCR products.
All 112 ampliconswere amplified using a universal
touchdown PCR program. The temperature cycling
protocol consisted of an initial denaturation step at
94 °C for 2 min, followed by 12 cycles of denaturation
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at 94 °C for 20 s, annealing starting at 58 °C for 20 s
(decreasing 1 °C per cycle), and extension at 72 °C for
1 min. This initial PCR reaction was followed by 25
additional cycles of denaturation at 94 °C for 40 s, an-
nealing at 46 °C for 40 s, and extension at 72 °C for 30 s.
Final extensionwas accomplished at 72 °Cover 10min.
After amplification, PCRproducts were denatured
at 95 °C for 5min and cooled (1.7 °C/s) in a thermocy-
cler block to 25 °C to form heteroduplexes.
MELTING ACQUISITION AND MELTING ANALYSIS
Melting acquisition was performed on the 96-well
Lightscanner (Idaho Technology Inc.) and the Light-
Cycler 480 (Roche). According to the manufacturer’s
instructions, we transferred 10 L PCR product to 96-
well plates suitable for high-resolutionmelting analysis
[Lightscanner, 4Titude plates (BioKe´); LightCycler
480, Roche]. To prevent evaporation during heating on
the Lightscanner, PCR products were covered with a
mineral oil overlay. We used a 10-min centrifugation
step instead of the 1-min centrifugation specified in the
manual. The longer centrifugation turned out to be
helpful in the elimination of air bubbles that rise to the
surface during the melting process, disturbing the flu-
orescent curves. The plates on the Lightscanner were
heated from 70 °C to 98 °C at 0.1 °C/s.
For the LightCycler 480, the appropriate 96-well
plates (Roche) were covered with the accompanying
sealing foils. The applied template for high-resolution
melting included first-step heating to 95 °C and amelt-
ing program that went from 55 °C to 95 °C.
Melting curve analysis was performed on the
Lightscanner with Lightscanner software (version 1.5)
and on the LightCycler 480 with the gene-scanning
module (version 1.3). Both software programs employ
a 3-step analysis: 1) normalization by selecting linear
regions before (100% fluorescence) and after (0% flu-
orescence) themelting transition, 2) temperature shift-
ing by moving the curves along the x-axis, facilitating
grouping, and 3) use of the Autogroup function. Shape
differences were further analyzed by subtracting the
curves from a reference curve, generating a difference




For BRCA1, we analyzed with high-resolution melting
97 known heterozygous sequence variants (78 patho-
genic mutations, 15 unclassified variants, and 4 poly-
morphisms) spread over 42 of 45 amplicons on the
Lightscanner and the LightCycler 480 instruments. To
validate the technique for BRCA2, we analyzed 115
known sequence variants (58 pathogenicmutations, 33
unclassified variants, and 24 polymorphisms) spread
over 58 of 67 amplicons. The melting curves of the
positive controls were compared with those of control
individuals. We did not have sequence variants avail-
able for 12 amplicons and verified their quality by an-
alyzing 8 wild-type samples. For this part of our study,
a total of 1057 fragments were scanned on both
instruments.
With the Lightscanner instrument, all 97 known
heterozygous BRCA1 sequence variants were detected
by analysis on the normal sensitivity setting. In addi-
tion, 15 single nucleotide polymorphisms (SNPs) were
detected in the healthy control individuals and con-
firmed by sequencing. On the LightCycler 480, only 92
of 97 (94.8%) of the BRCA1-positive controls were de-
tectedwith the default sensitivity setting of 0.3. Increas-
ing the sensitivity setting to 0.5 led to 100% detection
(97 of 97). The variants undetectable at 0.3 shared no
specific features—they had no common positions in
the fragments, and deletions as well as insertions, tran-
sitions, and transversions were missed (examples are
shown in Supplementary Fig. 1 in the online Data
Supplement).
On the Lightscanner, all 115 known heterozygous
BRCA2 sequence variants were easily detected, except
c.1909  22insT. This polymorphism is an insert of a
thymine in a row of 12 thymines in intron 10, and the
pre- and postmelt values had to be carefully adjusted to
make this variant detectable (panels are shown in Sup-
plementary Fig. 1 in the online Data Supplement). On
the LightCycler 480, 9 of 115 positive controls were not
detected with the default 0.3 sensitivity setting (sensi-
tivity 92%). Analysis of the melting curves on sensitiv-
ity setting 0.5 led to 100% detection. Detection of the
c.1909  22insT variant was again possible only after
carefully adjusting the pre- and postmelt parameters.
Hence, we detected all possible heterozygous com-
binations of bases (A/T, A/C, A/G, C/G, C/T, and G/T)
with high-resolution melting on both instruments.
Also, deletions and insertions of different sizes (1–63
bp) were easily distinguished from wild-type samples
(examples shown in Supplementary Fig. 1 in the online
Data Supplement). Frameshift mutations are the most
frequently detected mutations in BRCA1/2.
As mutations in the BRCA1 and BRCA2 genes are
autosomal dominant, we tested only a limited number
of homozygous (polymorphic) variants on both in-
struments. When only the standard temperature shift-
ing was used, both instruments could distinguish wild-
type sequences from sequences with heterozygous and
homozygous SNPs. An example is shown in Fig. 1.
SPECIFICITY
To determine the specificity of high-resolution melt-
ing, we performed a blind screening of 22 patients for
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BRCA1 and BRCA2. We had previously screened 11
patients with sequencing for exon 11 and DGGE for all
other coding exons and splice sites of BRCA1 and
BRCA2. The other 11 patients were screenedwith high-
resolution melting, and simultaneously all amplicons
were sequenced. The analysis was performed on nor-
mal sensitivity setting on the Lightscanner and sensi-
tivity settings 0.3, 0.5, and 0.7 on the LightCycler 480.
Fig. 1. Detection of heterozygous and homozygous SNPs on both instruments.
Difference plots and melting curves for BRCA1 fragment 11-8 on the Lightscanner and LightCycler 480. All samples were
amplified and analyzed in duplicate. The similarity of the curves for the duplicate samples illustrates the robustness of the
conditions applied. SNP BRCA1 c.3667AG is shown. Both instruments could easily distinguish the wild-type homozygous (grey
baselines) from the heterozygous (black) and homozygous mutant (dotted) melting curves. The melting curves illustrate that
mutant homozygous variants are detected by a Tm shift rather than by an altered curve shape. By the use of the default Tm
shift setting (that accounts for small temperature variations across the block) on both instruments, most of the homozygous
SNPs were detected. There is a 2 °C difference in Tm for these amplicons between the 2 instruments, probably due to internal
calibration. Temp, temperature.
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All sequence variants were detected on the Light-
scanner, confirming the 100% sensitivity. However, we
observed 32 false positives (confirmed by direct se-
quencing) in the 2464 amplicons analyzed (22 patients
screened for 112 amplicons), i.e., a specificity of 98.7%.
On the LightCycler 480, 87 sequence variations
were missed with the standard sensitivity setting of
0.3. A specificity of 98.6% (35 false positives in 2464
fragments) was calculated. As we did not detect all
genetic variants without highly adjusting the pre-
and postmelt parameters on sensitivity setting 0.5,
we reanalyzed our data with sensitivity setting 0.7.
This led to a detection of all known genetic variants;
however, the specificity dropped slightly to 95.9%
(102 false positives of 2464 fragments). An overview
of the high-resolution melting specificity per exon is
given in Fig. 2.
Discussion
The aim of this study was to evaluate and validate high-
resolution melting curve analysis for mutation detec-
tion on 2 distinct instruments. The Lightscanner in-
strument (Idaho Technology) is specially designed for
high-resolution melting analysis, and the LightCycler
480 (Roche)was originally launched as a real-timePCR
instrument.We used the BRCA1 and BRCA2 genes as a
model to evaluate the high-throughput capacity of the
high-resolution melting technique because these large
breast cancer susceptibility genes are being analyzed
worldwide in an increasing number of patients.
We designed 112 PCR amplicons, all amplifiable
with 1 PCR program, covering the complete coding
region of both BRCA1 and BRCA2 for high-resolution
melting analysis using LCGreen Plus as saturating dye.
To accomplish our high-throughput setup, PCR reac-
tions were not performed on the thermocycler present
in the LightCycler 480. On both instruments, minimal
post-PCR handling is required and analyses can be
done very fast.
We evaluated the sensitivity and specificity of
high-resolution melting on the 96-well Lightscanner
and LightCycler 480 instruments by analysis of 3521
PCR amplicons in total, the largest and most thorough
study on both instruments so far. We detected all
known sequence variants on both the Lightscanner
(normal sensitivity setting) and the LightCycler 480
(sensitivity setting 0.7). For sensitivity setting 0.5 on
the LightCycler 480, it was possible to detect all se-
quence variants only by carefully adjusting the pre- and
postmelting parameters. In a diagnostic setting, we rec-
ommend analyzing samples on sensitivity setting 0.7 to
overcome false negatives.
Previously, 100% sensitivity for high-resolution
melting analysis was reported for PCR products up to
300 bp (7 ) or 400 bp (6 ). This was confirmed by Ken-
nerson et al. (8 ) in a small study onmutation scanning
of 4 amplicons of the GJB1 gene in the 96-well Light-
scanner. These investigators also found 100% sensitiv-
ity from a validation of high-resolution melting analy-
sis with 18 positive control samples, followed by a blind
study of 10 patients. As the new gene scanning software
module was only recently made available on the Light-
Cycler 480, we were able to find data from only one
other study (9 ) comparing the results of both instru-
ments for factor VIII mutations. The investigators
missed 2 of 20 mutations on both instruments using
their settings. Because we obtained 100% sensitivity
(with the 0.7 sensitivity setting), gene scanning on the
LightCycler 480 also seems to be a valuable method.
For specificity, however, the Lightscanner scored
slightly better than the LightCycler 480 on a sensitivity
setting of 0.7. The decrease of the specificity on the
LightCycler 480 was caused by increasing the sensitiv-
ity setting from the default value of 0.3 and led to se-
quencing of about 70 more amplicons than the
Lightscanner.
In a recent study, Herrmann et al. (10) compared
the melting profile of a 110-bp fragment on different
instruments. They concluded that the ability to accu-
rately genotype single-base changes by amplicon melt-
ing is limited by the spatial temperature variation
across the plate, which is lower on the Lightscanner
than the on the LightCycle 480. This could explain the
somewhat lower specificity found on the LightCycler
480. The specificity of high-resolutionmelting analysis
was also studied by Reed and Wittwer (7 ) with engi-
neered plasmids. They reported 100% specificity for
PCRproducts up to 300 bp, and the specificity was only
slightly lowered (99.4%) for larger fragments. Our
somewhat lower specificity rate may be due to the use
of complex genomic DNA (instead of plasmids) or to
the high number of amplicons that we analyzed to
screen the complete coding regions of 2 large genes.
We also found that PCR conditions need to be well
optimized to obtain high values for specificity and
sensitivity. After optimization, PCR fragments need to
be verified by high-resolution melting curve analysis
for several individuals to find out if the curves are
reproducible.
We conclude from our data that high-resolution
melting analysis is at least as sensitive as other com-
monly used prescreening methods such as DGGE,
dHPLC, or fluorescent conformation-sensitive gel
electrophoresis (F-CSGE). Sensitivities and specifici-
ties of 100% are reported for these techniques (4, 11–
13). However, a recent comparison (14)of dHPLCand
high-resolution melting found better sensitivity and
specificity for the latter. The major advantage of high-
resolution melting is the minimal post-PCR require-
986 Clinical Chemistry 54:6 (2008)
ment, making it a less labor-intensive method while
improving its cost-effectiveness, ease of use, and
throughput.
In the present study, we detected several homozy-
gous SNPs by high-resolution melting. We used the
standard Tm shift analysis mode (to facilitate group-
ing). A large study on the detection of homozygous
SNPs was performed by Liew et al. (15), who con-
cluded that approximately 4% (class 3 or 4) of homo-
zygous human SNPs will remain undetectable by high-
resolution melting due to the small Tm difference
generated by homozygous C/G and A/T SNPs. The ho-
Fig. 2. Specificity per exon for BRCA1 and BRCA2 by the Lightscanner and the LightCycler 480 with 2 different
sensitivity settings.
High-Resolution Melting for Mutation Scanning of BRCA1/2
Clinical Chemistry 54:6 (2008) 987
mozygous SNPs detected in the present study were in-
deed class 1 (C/T or G/A) and class 2 (C/A orG/T). The
problem for the class 3 or 4 SNPs might be overcome
by mixing samples with wild-type fragments. This
could also be useful when high-resolution melting
analysis is applied for mutational analysis of genes as-
sociated with recessive diseases or males with X-linked
diseases.
From our observations, it became clear that the
software is not always able to discriminate between dis-
tinct variants within the same amplicon. As an exam-
ple, we found that the 2 SNPs BRCA1 c.3113AG and
BRCA1 c.3119 GA were classified in the same group
by the software (data not shown). This can be ex-
plained by the short distance and the small Tm varia-
tion between these 2 aberrations. In Fig. 3, however, we
show a common polymorphism (BRCA1 c.2934 TG)
grouped together with 2 distinct pathogenic mutations
(BRCA1 c.3012delG and BRCA1 c.2989_2990dupA).
This example illustrates that although high-resolution
melting analysis is a very useful prescreening tech-
nique, all detected aberrations still need to be se-
quenced in a diagnostic setting. Recent advances in the
use of unlabeled oligonucleotides will substantially
reduce the sequencing work, as these approaches al-
low discrimination between different genetic variants
within the same amplicon (16). An alternative way
for genotyping specific polymorphisms or distinct se-
quence aberrations was recently proposed by Do-
browolski et al. (17). They designed a multiplex, short
amplicon (146–266 bp) assay with primers flanking
the aberrations and described the use of melt controls.
High-resolution melting is a mutation scanning
technique suitable for the detection of point muta-
tions. However, like other PCR-based techniques,
large exon (ormulti-exon) deletions will remain unde-
tected. In some populations, large intragenic BRCA1/2
deletions represent an important fraction of the muta-
tion spectrum due to founder effects. For a complete
mutation detection strategy, additional techniques
such as multiplex ligation-dependent probe amplifica-
tion (MLPA) are required.
Our experiences with high-resolution melting for
theBRCA1/2 genes allowed us to readily implement the
technology for screening other large genes. However,
preliminary data showed that pooling samples ex-
tracted in different laboratories produced variations in
melting curves. We hypothesize that the differences in
DNA-extraction methods may have influenced the re-
sults. The composition of the DNA solution buffer
Fig. 3. Different sequence variants classified together by high-resolution melting.
Melting curves and difference plots for fragment BRCA1 11-14 on the Lightscanner and the LightCycler 480. A common
polymorphism (BRCA1 c.2934TG) is grouped together with 2 distinct pathogenic mutations (BRCA1 c.3012delG and BRCA1
c.2989_2990dupA). These panels illustrate that every variation in the melting curves needs to be sequenced.
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might play an important role. The same findings were
reported in a recent study of Seipp et al. (18)—ampli-
con Tm differences up to 0.39 °C were found when
different DNA extraction methods were used.
In summary, we present a fast and reliable muta-
tion detection strategy by high-resolution melting
analysis on 2 different instruments. By introducing this
method, our reporting time for the BRCA genes can be
reduced considerably (one third compared to direct
sequencing and DGGE). In our setup, the hands-on
postmelt analysis of 11 patients requires only 3 h (ap-
proximately 13 min per 96-well plate) followed by
sequencing of the detected aberrations. Owing to the
relatively low cost of the consumables (LCGreen Plus;
no need of fluorescence-labeled primers or special
polymers) and the lower workload compared with
othermutation scanning techniques, this is a very cost-
efficient technology. The 2 high-resolution melting in-
struments evaluated were able to detect all known se-
quence variants. As suggested by Herrmann et al. (10),
we also found that the Lightscanner, specifically de-
signed for high-resolution melting, displayed slightly
better scanning specificity than the LightCycler 480, an
instrument that can also be used for real-time Q-PCR.
Further reduction of the sequencing burden can be
obtained using unlabeled probes for the detection of
frequent SNPs in both genes. We conclude that high-
resolution melting is a rapid, cost-efficient, sensitive
methodology simple enough to be readily imple-
mented in a diagnostic laboratory.
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